Anemia in inflammatory bowel disease: A neglected issue with relevant effects

World Journal of Gastroenterology

Volumn 20, Issue 13, 2014, Pages 3542-3551

  Guagnozzi, Danila ^a   Lucendo, Alfredo J ^a  

^a HOSPITAL GENERAL DE TOMELLOSO   (Spain)

Author keywords

Anemia; Anemia of chronic disease; Erythropoietin; Inflammatory bowel disease; Iron deficiency

Indexed keywords

CYANOCOBALAMIN; CYTOKINE; FERRIC CARBOXYMALTOSE; FERRITIN; FERROPORTIN; HEMOGLOBIN; HEPCIDIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; IRON; ISOMALTOSE; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ERYTHROPOIETIN;

ANEMIA; ARTICLE; BONE MARROW DEPRESSION; BONE MARROW SUPPRESSION; CROHN DISEASE; CYANOCOBALAMIN DEFICIENCY; DISEASE SEVERITY; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FOLLOW UP; HEMATOLOGICAL PARAMETERS; HUMAN; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; IRON ABSORPTION; IRON DEFICIENCY ANEMIA; NONHUMAN; PATHOPHYSIOLOGY; PHASE 3 CLINICAL TRIAL (TOPIC); PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENT DISEASE; SUPPLEMENTATION; SYSTEMATIC REVIEW (TOPIC); ULCERATIVE COLITIS; BLOOD; COMPLICATION; DIET SUPPLEMENTATION; FOLIC ACID DEFICIENCY; HEMOLYSIS; METABOLISM; PROGNOSIS;

ANEMIA; ANEMIA, IRON-DEFICIENCY; CYTOKINES; DIETARY SUPPLEMENTS; ERYTHROPOIETIN; FERRITINS; FOLIC ACID DEFICIENCY; HEMOLYSIS; HEPCIDINS; HUMANS; INFLAMMATORY BOWEL DISEASES; IRON; PROGNOSIS; QUALITY OF LIFE; VITAMIN B 12 DEFICIENCY;

EID: 84897544141     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i13.3542     Document Type: Article

References (110)

1. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-1023 [PMID: 15758012 DOI: 10.1056/ NEJMra041809]
2. Weiss G, Gasche C. Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologica 2010; 95: 175-178 [PMID: 20139387 DOI: 10.3324/haematol.2009.017046]
3. Gomollón F, Gisbert JP. Anemia and inflammatory bowel diseases. World J Gastroenterol 2009; 15: 4659-4665 [PMID: 19787829 DOI: 10.3748/wjg.15.4659]
4. Cucino C, Sonnenberg A. Cause of death in patients with inflammatory bowel disease. Inflamm Bowel Dis 2001; 7: 250-255 [PMID: 11515852 DOI: 10.1097/00054725-200108000-00011]
5. Pizzi LT, Weston CM, Goldfarb NI, Moretti D, Cobb N, Howell JB, Infantolino A, Dimarino AJ, Cohen S. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 47-52 [PMID: 16374258 DOI: 10.1097/01.MIB.0000191670.04605.e7]
6. Wells CW, Lewis S, Barton JR, Corbett S. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006; 12: 123-130 [PMID: 16432377 DOI: 10.1097/01. MIB.0000196646.64615.db]
7. Liu K, Kaffes AJ. Iron deficiency anaemia: a review of diagnosis, investigation and management. Eur J Gastroenterol Hepatol 2012; 24: 109-116 [PMID: 22157204 DOI: 10.1097/ MEG.0b013e32834f3140]
8. Ott C, Liebold A, Takses A, Strauch UG, Obermeier F. High prevalence but insufficient treatment of iron-deficiency anemia in patients with inflammatory bowel disease: results of a population-based cohort. Gastroenterol Res Pract 2012; 2012: 595970 [PMID: 22899905 DOI: 10.1155/2012/595970]
9. Gasche C, Lomer MC, Cavill I, Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut 2004; 53: 1190-1197 [PMID: 15247190 DOI: 10.1136/gut.2003.035758]
10. Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med 2004; 116 Suppl 7A: 44S-49S [PMID: 15050885 DOI: 10.1016/j.amjmed.2003.12.011]
11. Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006; 24: 1507-1523 [PMID: 17206940 DOI: 10.1111/j.1365-2036.2006.03146.x]
12. Bergamaschi G, Di Sabatino A, Albertini R, Ardizzone S, Biancheri P, Bonetti E, Cassinotti A, Cazzola P, Markopoulos K, Massari A, Rosti V, Porro GB, Corazza GR. Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment. Haematologica 2010; 95: 199-205 [PMID: 19815838 DOI: 10.3324/ haematol.2009.009985]
13. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968; 405: 5-37 [PMID: 4975372]
14. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 2006; 107: 1747-1750 [PMID: 16189263 DOI: 10.1182/blood-2005-07-3046]
15. Patel KV, Harris TB, Faulhaber M, Angleman SB, Connelly S, Bauer DC, Kuller LH, Newman AB, Guralnik JM. Racial variation in the relationship of anemia with mortality and mobility disability among older adults. Blood 2007; 109: 4663-4670 [PMID: 17284526 DOI: 10.1182/blood-2006-10-055384]
16. Rejler M, Tholstrup J, Andersson-Gäre B, Spångéus A. Low prevalence of anemia in inflammatory bowel disease: a population-based study in Sweden. Scand J Gastroenterol 2012; 47: 937-942 [PMID: 22571405 DOI: 10.3109/00365521.2012.67259 0]
17. Gerasimidis K, Barclay A, Papangelou A, Missiou D, Buchanan E, Tracey C, Tayler R, Russell RK, Edwards CA, McGrogan P. The epidemiology of anemia in pediatric inflammatory bowel disease: prevalence and associated factors at diagnosis and follow-up and the impact of exclusive enteral nutrition. Inflamm Bowel Dis 2013; 19: 2411-2422 [PMID: 23899546 DOI: 10.1097/MIB.0b013e31829ed855]
18. Vijverman A, Piront P, Belaiche J, Louis E. Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003. Acta Gastroenterol Belg 2006; 69: 1-4 [PMID: 16673554]
19. Stein J, Hartmann F, Dignass AU. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol 2010; 7: 599-610 [PMID: 20924367 DOI: 10.1038/nrgastro.2010.151]
20. Bergamaschi G, Di Sabatino A, Albertini R, Costanzo F, Guerci M, Masotti M, Pasini A, Massari A, Campostrini N, Corbella M, Girelli D, Corazza GR. Serum hepcidin in inflammatory bowel diseases: biological and clinical significance. Inflamm Bowel Dis 2013; 19: 2166-2172 [PMID: 23867871 DOI: 10.1097/MIB.0b013e31829a6e43]
21. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306: 2090-2093 [PMID: 15514116 DOI: 10.1126/science.1104742]
22. Theurl I, Mattle V, Seifert M, Mariani M, Marth C, Weiss G. Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. Blood 2006; 107: 4142-4148 [PMID: 16434484 DOI: 10.1182/ blood-2005-08-3364]
23. Knutson MD, Oukka M, Koss LM, Aydemir F, Wessling-Resnick M. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci USA 2005; 102: 1324-1328 [PMID: 15665091 DOI: 10.1073/ pnas.0409409102]
24. de la Morena F, Gisbert JP. [Anemia and inflammatory bowel disease]. Rev Esp Enferm Dig 2008; 100: 285-293 [PMID: 18662081]
25. Reinisch W, Staun M, Bhandari S, Muñoz M. State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. J Crohns Colitis 2013; 7: 429-440 [PMID: 22917870 DOI: 10.1016/j.crohns.2012.07.031]
26. Means RT. Recent developments in the anemia of chronic disease. Curr Hematol Rep 2003; 2: 116-121 [PMID: 12901142]
27. Dallalio G, Law E, Means RT. Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Blood 2006; 107: 2702-2704 [PMID: 16332970 DOI: 10.1182/blood-2005-07-2854]
28. Cazzola M, Ponchio L, de Benedetti F, Ravelli A, Rosti V, Beguin Y, Invernizzi R, Barosi G, Martini A. Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic onset juvenile chronic arthritis. Blood 1996; 87: 4824-4830 [PMID: 8639855]
29. Sandborn W. Erythropoietin for inflammatory bowel disease anemia. Gastroenterology 1997; 112: 660-661 [PMID: 9024321 DOI: 10.1053/gast.1997.v112.agast970660]
30. Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res 1998; 18: 555-559 [PMID: 9726435 DOI: 10.1089/jir.1998.18.555]
31. Dieleman LA, Heizer WD. Nutritional issues in inflammatory bowel disease. Gastroenterol Clin North Am 1998; 27: 435-451 [PMID: 9650026 DOI: 10.1016/S0889-8553(05)70012-1]
32. Lucendo AJ, De Rezende LC. Importance of nutrition in inflammatory bowel disease. World J Gastroenterol 2009; 15: 2081-2088 [PMID: 19418580 DOI: 10.3748/wjg.15.2081]
33. Guagnozzi D, González-Castillo S, Olveira A, Lucendo AJ. Nutritional treatment in inflammatory bowel disease. An update. Rev Esp Enferm Dig 2012; 104: 479-488 [PMID: 23130856 DOI: 10.4321/S1130-01082012000900006]
34. Lambert D, Benhayoun S, Adjalla C, Gelot MA, Renkes P, Felden F, Gerard P, Belleville F, Gaucher P, Guéant JL, Nicolas JP. Crohn's disease and vitamin B12 metabolism. Dig Dis Sci 1996; 41: 1417-1422 [PMID: 8689919 DOI: 10.1007/ BF02088567]
35. Shaw S, Jayatilleke E, Meyers S, Colman N, Herzlich B, Herbert V. The ileum is the major site of absorption of vitamin B12 analogues. Am J Gastroenterol 1989; 84: 22-26 [PMID: 2912026]
36. Hoffbrand V, Provan D. ABC of clinical haematology. Macrocytic anaemias. BMJ 1997; 314: 430-433 [PMID: 9040391 DOI: 10.1136/bmj.314.7078.430]
37. Bermejo F, Algaba A, Guerra I, Chaparro M, De-La-Poza G, Valer P, Piqueras B, Bermejo A, García-Alonso J, Pérez MJ, Gisbert JP. Should we monitor vitamin B12 and folate levels in Crohn's disease patients? Scand J Gastroenterol 2013; 48: 1272-1277 [PMID: 24063425 DOI: 10.3109/00365521.2013.836 752]
38. M'Koma AE. Follow-up results of hematology data before and after restorative proctocolectomy. Clinical outcome. Dis Colon Rectum 1994; 37: 932-937 [PMID: 8076494 DOI: 10.1007/BF02052601]
39. Yates P, Macht LM, Williams NA, Elson CJ. Red cell autoantibody production by colonic mononuclear cells from a patient with ulcerative colitis and autoimmune haemolytic anaemia. Br J Haematol 1992; 82: 753-756 [PMID: 1482663 DOI: 10.1111/j.1365-2141.1992.tb06954.x]
40. Giannadaki E, Potamianos S, Roussomoustakaki M, Kyriakou D, Fragkiadakis N, Manousos ON. Autoimmune hemolytic anemia and positive Coombs test associated with ulcerative colitis. Am J Gastroenterol 1997; 92: 1872-1874 [PMID: 9382055]
41. Lorber M, Schwartz LI, Wasserman LR. Association of antibody-coated red blood cells with ulcerative colitis; report of four cases. Am J Med 1955; 19: 887-894 [PMID: 13275484 DOI: 10.1016/0002-9343(55)90156-X]
42. Wang Z, Zhou Y, Liu Y. Concurrent inflammatory bowel disease and myelodysplastic syndrome: report of nine new cases and a review of the literature. Dig Dis Sci 2008; 53: 1929-1932 [PMID: 18080760 DOI: 10.1007/s10620-007-0090-0]
43. Harewood GC, Loftus EV, Tefferi A, Tremaine WJ, Sandborn WJ. Concurrent inflammatory bowel disease and myelodysplastic syndromes. Inflamm Bowel Dis 1999; 5: 98-103 [PMID: 10338378 DOI: 10.1097/00054725-199905000-00005]
44. Eng C, Farraye FA, Shulman LN, Peppercorn MA, Krauss CM, Connors JM, Stone RM. The association between the myelodysplastic syndromes and Crohn disease. Ann Intern Med 1992; 117: 661-662 [PMID: 1530197 DOI: 10.7326/0003-4 819-117-8-661]
45. Nakamura F, Watanabe T, Hori K, Ohara Y, Yamashita K, Tsuji Y, Ueda Y, Mikami S, Nakase H, Chiba T. Simultaneous occurrence of inflammatory bowel disease and myelodysplastic syndrome due to chromosomal abnormalities in bone marrow cells. Digestion 2009; 79: 215-219 [PMID: 19390193 DOI: 10.1159/000213486]
46. Wakefield AJ, Sankey EA, Dhillon AP, Sawyerr AM, More L, Sim R, Pittilo RM, Rowles PM, Hudson M, Lewis AA. Granulomatous vasculitis in Crohn's disease. Gastroenterology 1991; 100: 1279-1287 [PMID: 2013373]
47. Karran P. Thiopurines, DNA damage, DNA repair and therapy-related cancer. Br Med Bull 2006; 153-170 [PMID: 17277075 DOI: 10.1093/bmb/ldl020]
48. Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, Hébuterne X, Cortot A, Bouhnik Y, Gendre JP, Simon T, Maynadié M, Hermine O, Faivre J, Carrat F. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet 2009; 374: 1617-1625 [PMID: 19837455 DOI: 10.1016/S0140-6736(09)61302-7]
49. Annibale B, Capurso G, Chistolini A, D'Ambra G, DiGiulio E, Monarca B, DelleFave G. Gastrointestinal causes of refractory iron deficiency anemia in patients without gastrointestinal symptoms. Am J Med 2001; 111: 439-445 [PMID: 11690568 DOI: 10.1016/S0002-9343(01)00883-X]
50. Guagnozzi D, Lucendo AJ. Colorectal cancer surveillance in patients with inflammatory bowel disease: What is new? World J Gastrointest Endosc 2012; 4: 108-116 [PMID: 22523611 DOI: 10.4253/wjge.v4.i4.108]
51. Gasche C, Berstad A, Befrits R, Beglinger C, Dignass A, Erichsen K, Gomollon F, Hjortswang H, Koutroubakis I, Kulnigg S, Oldenburg B, Rampton D, Schroeder O, Stein J, Travis S, Van Assche G. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007; 13: 1545-1553 [PMID: 17985376 DOI: 10.1002/ibd.20285]
52. Oldenburg B, Koningsberger JC, Van Berge Henegouwen GP, Van Asbeck BS, Marx JJ. Iron and inflammatory bowel disease. Aliment Pharmacol Ther 2001; 15: 429-438 [PMID: 11284771 DOI: 10.1046/j.1365-2036.2001.00930.x]
53. Tsiolakidou G, Koutroubakis IE. Stimulating erythropoiesis in inflammatory bowel disease associated anemia. World J Gastroenterol 2007; 13: 4798-4806 [PMID: 17828809]
54. Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, Sonnweber T, Eberwein L, Witcher DR, Murphy AT, Wroblewski VJ, Wurz E, Datz C, Weiss G. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 2009; 113: 5277-5286 [PMID: 19293425 DOI: 10.1182/ blood-2008-12-195651]
55. Gasche C, Evstatiev R, Haas T, Kaser A, Knoflach P, Petritsch W, Weiss G, Reinisch W. [Diagnosis and treatment of iron deficiency and anaemia in inflammatory bowel diseases. Consensus of the Austrian IBD Working Party]. Z Gastroenterol 2011; 49: 627-632 [PMID: 21526463 DOI: 10.1055/ s-0031-1273324]
56. Muñoz M, García-Erce JA, Remacha Á.F. Disorders of iron metabolism. Part II: iron deficiency and iron overload. J Clin Pathol 2011; 64: 287-296 [PMID: 21177268 DOI: 10.1136/ jcp.2010.086991]
57. Muñoz M, García-Erce JA, Remacha AF. Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis. J Clin Pathol 2011; 64: 281-286 [PMID: 21177266 DOI: 10.1136/ jcp.2010.079046]
58. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002; 48: 1066-1076 [PMID: 12089176]
59. Punnonen K, Irjala K, Rajamäki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997; 89: 1052-1057 [PMID: 9028338]
60. Beguin Y, Clemons GK, Pootrakul P, Fillet G. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin recep tor and erythropoietin. Blood 1993; 81: 1067-1076 [PMID: 8427988]
61. Oustamanolakis P, Koutroubakis IE, Messaritakis I, Malliaraki N, Sfiridaki A, Kouroumalis EA. Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2011; 23: 262-268 [PMID: 21285884 DOI: 10.1097/MEG.0b013e328343b885]
62. Thomas C, Kobold U, Balan S, Roeddiger R, Thomas L. Serum hepcidin-25 may replace the ferritin index in the Thomas plot in assessing iron status in anemic patients. Int J Lab Hematol 2011; 33: 187-193 [PMID: 20868446 DOI: 10.1111/j.1751-553X.2010.01265.x]
63. Oustamanolakis P, Koutroubakis IE, Messaritakis I, Kefalogiannis G, Niniraki M, Kouroumalis EA. Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease. J Crohns Colitis 2011; 5: 295-300 [PMID: 21683299 DOI: 10.1016/j.crohns.2011.02.002]
64. Recommendations to prevent and control iron deficiency in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47: 1-29 [PMID: 9563847]
65. Rimon E, Kagansky N, Kagansky M, Mechnick L, Mashiah T, Namir M, Levy S. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med 2005; 118: 1142-1147 [PMID: 16194646 DOI: 10.1016/j.amjmed.2005.01.065]
66. Zlotkin S, Arthur P, Antwi KY, Yeung G. Randomized, controlled trial of single versus 3-times-daily ferrous sulfate drops for treatment of anemia. Pediatrics 2001; 108: 613-616 [PMID: 11533326 DOI: 10.1542/peds.108.3.613]
67. Makrides M, Crowther CA, Gibson RA, Gibson RS, Skeaff CM. Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial. Am J Clin Nutr 2003; 78: 145-153 [PMID: 12816784]
68. de Silva AD, Tsironi E, Feakins RM, Rampton DS. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther 2005; 22: 1097-1105 [PMID: 16305723 DOI: 10.1111/ j.1365-2036.2005.02700.x]
69. Gisbert JP, Bermejo F, Pajares R, Pérez-Calle JL, Rodríguez M, Algaba A, Mancenido N, de la Morena F, Carneros JA, McNicholl AG, González-Lama Y, Maté J. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement. Inflamm Bowel Dis 2009; 15: 1485-1491 [PMID: 19408339 DOI: 10.1002/ ibd.20925]
70. Werner T, Wagner SJ, Martínez I, Walter J, Chang JS, Clavel T, Kisling S, Schuemann K, Haller D. Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis. Gut 2011; 60: 325-333 [PMID: 21076126 DOI: 10.1136/ gut.2010.216929]
71. Seril DN, Liao J, Ho KL, Warsi A, Yang CS, Yang GY. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci 2002; 47: 1266-1278 [PMID: 12064801 DOI: 10.1023/A:1015362228659]
72. Carrier J, Aghdassi E, Platt I, Cullen J, Allard JP. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther 2001; 15: 1989-1999 [PMID: 11736731 DOI: 10.1046/ j.1365-2036.2001.01113.x]
73. Erichsen K, Ulvik RJ, Grimstad T, Berstad A, Berge RK, Hausken T. Effects of ferrous sulphate and non-ionic ironpolymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005; 22: 831-838 [PMID: 16225492 DOI: 10.1111/ j.1365-2036.2005.02652.x]
74. Reifen R, Matas Z, Zeidel L, Berkovitch Z, Bujanover Y. Iron supplementation may aggravate inflammatory status of colitis in a rat model. Dig Dis Sci 2000; 45: 394-397 [PMID: 10711457 DOI: 10.1023/A:1005437331967]
75. Dostal A, Chassard C, Hilty FM, Zimmermann MB, Jaeggi T, Rossi S, Lacroix C. Iron depletion and repletion with ferrous sulfate or electrolytic iron modifies the composition and metabolic activity of the gut microbiota in rats. J Nutr 2012; 142: 271-277 [PMID: 22190022 DOI: 10.3945/jn.111.148643]
76. Lee TW, Kolber MR, Fedorak RN, van Zanten SV. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and metaanalysis. J Crohns Colitis 2012; 6: 267-275 [PMID: 22405161 DOI: 10.1016/j.crohns.2011.09.010]
77. Schröder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H, Reinshagen M, Schreiber S, Junge U, Schrott M, Stein J. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study. Am J Gastroenterol 2005; 100: 2503-2509 [PMID: 16279906 DOI: 10.1111/ j.1572-0241.2005.00250.x]
78. Gasche C, Waldhoer T, Feichtenschlager T, Male C, Mayer A, Mittermaier C, Petritsch W. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. Am J Gastroenterol 2001; 96: 2382-2387 [PMID: 11513178 DOI: 10.1111/j.1572-0241.2001.04094.x]
79. Bodemar G, Kechagias S, Almer S, Danielson BG. Treatment of anaemia in inflammatory bowel disease with iron sucrose. Scand J Gastroenterol 2004; 39: 454-458 [PMID: 15180183 DOI: 10.1080/00365520310008818-1]
80. García-López S, Gomollón F, García-Erce JA, Araméndiz R, Sicilia B, Vicente R. Intravenous iron sucrose: a simple, safe and quick method to treat anemia secondary to digestive diseases. Gastroenterology 2006; 130: A84
81. Lindgren S, Wikman O, Befrits R, Blom H, Eriksson A, Grännö C, Ung KA, Hjortswang H, Lindgren A, Unge P. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009; 44: 838-845 [PMID: 19330567 DOI: 10.1080/00365520902839667]
82. Koutroubakis IE, Oustamanolakis P, Karakoidas C, Mantzaris GJ, Kouroumalis EA. Safety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease. Dig Dis Sci 2010; 55: 2327-2331 [PMID: 19834803 DOI: 10.1007/s10620-009-1022-y]
83. Muñoz M, Gómez-Ramírez S, García-Erce JA. Intravenous iron in inflammatory bowel disease. World J Gastroenterol 2009; 15: 4666-4674 [PMID: 19787830 DOI: 10.3748/ wjg.15.4666]
84. Evstatiev R, Marteau P, Iqbal T, Khalif IL, Stein J, Bokemeyer B, Chopey IV, Gutzwiller FS, Riopel L, Gasche C. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology 2011; 141: 846-853.e1-2 [PMID: 21699794 DOI: 10.1053/j.gastro.2011.06.005]
85. Kulnigg S, Stoinov S, Simanenkov V, Dudar LV, Karnafel W, Garcia LC, Sambuelli AM, D'Haens G, Gasche C. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 2008; 103: 1182-1192 [PMID: 18371137 DOI: 10.1111/ j.1572-0241.2007.01744.x]
86. Evstatiev R, Alexeeva O, Bokemeyer B, Chopey I, Felder M, Gudehus M, Iqbal T, Khalif I, Marteau P, Stein J, Gasche C. Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2013; 11: 269-277 [PMID: 23078888 DOI: 10.1016/ j.cgh.2012.10.013]
87. Kulnigg S, Teischinger L, Dejaco C, Waldhör T, Gasche C. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. Am J Gastroenterol 2009; 104: 1460-1467 [PMID: 19491860 DOI: 10.1038/ajg.2009.114]
88. Gasché C, Reinisch W, Lochs H, Parsaei B, Bakos S, Wyatt J, Fueger GF, Gangl A. Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency. Dig Dis Sci 1994; 39: 1930-1934 [PMID: 8082499]
89. Horina JH, Petritsch W, Schmid CR, Reicht G, Wenzl H, Silly H, Krejs GJ. Treatment of anemia in inflammatory bowel disease with recombinant human erythropoietin: results in three patients. Gastroenterology 1993; 104: 1828-1831 [PMID: 8500742]
90. Schreiber S, Howaldt S, Schnoor M, Nikolaus S, Bauditz J, Gasché C, Lochs H, Raedler A. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 1996; 334: 619-623 [PMID: 8592524 DOI: 10.1056/NEJM199603073341002]
91. Gasché C, Dejaco C, Waldhoer T, Tillinger W, Reinisch W, Fueger GF, Gangl A, Lochs H. Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial. Ann Intern Med 1997; 126: 782-787 [PMID: 9148651 DOI: 10.7326/0003-4819-126-10-199705150-0 0006]
92. Gasche C, Dejaco C, Reinisch W, Tillinger W, Waldhoer T, Fueger GF, Lochs H, Gangl A. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin. Digestion 1999; 60: 262-267 [PMID: 10343140 DOI: 10.1159/000007667]
93. Demirtürk L, Hülagü S, Yaylaci M, Altin M, Ozel M. Serum erythropoietin levels in patients with severe anemia secondary to inflammatory bowel disease and the use of recombinant human erythropoietin in patients with anemia refractory to treatment. Dis Colon Rectum 1995; 38: 896-897 [PMID: 7634987 DOI: 10.1007/BF02049850]
94. Koutroubakis IE, Karmiris K, Makreas S, Xidakis C, Niniraki M, Kouroumalis EA. Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in patients with inflammatory bowel disease and refractory anaemia: a pilot study. Eur J Gastroenterol Hepatol 2006; 18: 421-425 [PMID: 16538115 DOI: 10.1097/00042737-200604000-00017]
95. Dohil R, Hassall E, Wadsworth LD, Israel DM. Recombinant human erythropoietin for treatment of anemia of chronic disease in children with Crohn's disease. J Pediatr 1998; 132: 155-159 [PMID: 9470019 DOI: 10.1016/S0022-3476(98)70503-7]
96. Katsanos KH, Tatsioni A, Natsi D, Sigounas D, Christodoulou DK, Tsianos EV. Recombinant human erythropoietin in patients with inflammatory bowel disease and refractory anemia: a 15-year single center experience. J Crohns Colitis 2012; 6: 56-61 [PMID: 22261528 DOI: 10.1016/j.crohns.2011.07.004]
97. Cronin CC, Shanahan F. Anemia in patients with chronic inflammatory bowel disease. Am J Gastroenterol 2001; 96: 2296-2298 [PMID: 11513165 DOI: 10.1111/j.1572-0241.2001.04032.x]
98. Liu S, Ren J, Hong Z, Yan D, Gu G, Han G, Wang G, Ren H, Chen J, Li J. Efficacy of erythropoietin combined with enteral nutrition for the treatment of anemia in Crohn's disease: a prospective cohort study. Nutr Clin Pract 2013; 28: 120-127 [PMID: 23064018 DOI: 10.1177/0884533612462744]
99. Christodoulou DK, Tsianos EV. Anemia in inflammatory bowel disease-the role of recombinant human erythropoietin. Eur J Intern Med 2000; 11: 222-227 [PMID: 10967511 DOI: 10.1016/S0953-6205(00)00094-7]
100. Majumder S, Soriano J, Louie Cruz A, Dasanu CA. Vitamin B12 deficiency in patients undergoing bariatric surgery: preventive strategies and key recommendations. Surg Obes Relat Dis 2013; 9: 1013-1019 [PMID: 24091055 DOI: 10.1016/ j.soard.2013.04.017]
101. Mullin GE. Micronutrients and inflammatory bowel disease. Nutr Clin Pract 2012; 27: 136-137 [PMID: 22223669 DOI: 10.1177/0884533611433436]
102. Hvas AM, Nexo E. Diagnosis and treatment of vitamin B12 deficiency--an update. Haematologica 2006; 91: 1506-1512 [PMID: 17043022]
103. Delpre G, Stark P, Niv Y. Sublingual therapy for cobalamin deficiency as an alternative to oral and parenteral cobalamin supplementation. Lancet 1999; 354: 740-741 [PMID: 10475189 DOI: 10.1016/S0140-6736(99)02479-4]
104. Sharabi A, Cohen E, Sulkes J, Garty M. Replacement therapy for vitamin B12 deficiency: comparison between the sublingual and oral route. Br J Clin Pharmacol 2003; 56: 635-638 [PMID: 14616423 DOI: 10.1046/j.1365-2125.2003.01907.x]
105. Slot WB, Merkus FW, Van Deventer SJ, Tytgat GN. Normalization of plasma vitamin B12 concentration by intranasal hydroxocobalamin in vitamin B12-deficient patients. Gastroenterology 1997; 113: 430-433 [PMID: 9247460 DOI: 10.1053/ gast.1997.v113.pm9247460]
106. Johnson D, Bayele H, Johnston K, Tennant J, Srai SK, Sharp P. Tumour necrosis factor alpha regulates iron transport and transporter expression in human intestinal epithelial cells. FEBS Lett 2004; 573: 195-201 [PMID: 15327997 DOI: 10.1016/ j.febslet.2004.07.081]
107. Ludwiczek S, Aigner E, Theurl I, Weiss G. Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 2003; 101: 4148-4154 [PMID: 12522003 DOI: 10.1182/ blood-2002-08-2459]
108. Warsch S, Byrnes J. Emerging causes of iron deficiency anemia refractory to oral iron supplementation. World J Gastrointest Pharmacol Ther 2013; 4: 49-53 [PMID: 23919216 DOI: 10.4292/wjgpt.v4.i3.49]
109. Gomollón F, Gisbert JP. Current management of iron deficiency anemia in inflammatory bowel diseases: a practical guide. Drugs 2013; 73: 1761-1770 [PMID: 24114623 DOI: 10.1007/s40265-013-0131-2]
110. Gisbert JP, Gomollón F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 2008; 103: 1299-1307 [PMID: 18477354 DOI: 10.1111/j.1572-0241.2008.01846.x]